Meeting
2014 ASCO Annual Meeting
Racial/ethnic (RE) differences in the occurrence of HER2 and hormone receptor (HR)-defined breast cancer (BC) in California (CA).
Authors
Scarlett Lin Gomez
Cancer Prevention Institute of California (CPIC), Fremont, CA
Scarlett Lin Gomez , Lisa Wang , Laura Chu , Marjorie C. Green , Chunyan Song , Lisa M Moy , Juan Yang , Li Tao , Christina A Clarke
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer - HER2/ER
Track
Breast Cancer
Sub Track
HER2+
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 634)
DOI
10.1200/jco.2014.32.15_suppl.634
Abstract #
634
Poster Bd #
98
Abstract Disclosures
Similar Posters
Poster
2017 ASCO Annual Meeting
Survival by HER2 receptor status in stage IV breast cancer: SEER 2010-2012.
First Author: Alexandra Thomas
Poster
2023 ASCO Annual Meeting
Artificial intelligence–powered tumor-infiltrating lymphocytes analyzer to reveal distinct immune landscapes in breast cancer by molecular subtype and HER2 score.
First Author: Seunghwan Shin
Poster
2023 ASCO Annual Meeting
Metastatic patterns and outcomes by HER2 and hormone receptor (HR) status in patients (pts) with metastatic breast cancer (mBC).
First Author: Qianyu Yuan
Poster
2023 ASCO Annual Meeting
Clinical features, genomic landscapes, and survival outcomes of HER2-low breast cancer.
First Author: Jin Juan